Name | c-GpAp |
Synonyms | cGAMP c-GpAp C-GPAP di-GAMP di-cGAMP 3'3'-cGAMP cGAMP (Cyclic GMP-AMP 3''-Guanylic acid, adenylyl-(3''?5'')-, cyclic nucleotide 3',3'-Cyclic guanosine monophosphate-adenosine monophosphate |
CAS | 849214-04-6 |
Molecular Formula | C20H24N10O13P2 |
Molar Mass | 674.41 |
Density | 2.61±0.1 g/cm3(Predicted) |
Boling Point | 1159.9±75.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
Appearance | Morphological powder |
Color | white to beige |
pKa | 0.96±0.70(Predicted) |
Storage Condition | -20°C |
Physical and Chemical Properties | Bioactive 3 ',3'-cGAMP (3 ',3'-cyclic GMP-AMP, Cyclic GMP-AMP, cGAMP) activates endoplasmic reticulum (ER) endogenous receptor stimulator of interferon genes (STING), thereby inducing antiviral state and type I IFN secretion. |
In vitro study | cGAMP promotes the antigen-specific proliferation capacity of spleen cells in mice. cGAMP directly activates murine and human dendritic cells in vitro. On stimulation with cGAMP, fibroblasts from the patients showed increased transcription of IFNB1 but not of the genes encoding interleukin-1 (IL1), interleukin-6 (IL6), or tumor necrosis factor (TNF). cGAMP activates the endoplasmic reticulum (ER)-resident receptor STING, thereby inducing an antiviral state and the secretion of type I IFNs. |
In vivo study | cGAMP promotes the antigen-specific cytokine production by spleen cells of immunized mice. Animal Model: Female C57BL/6 (H-2b) mice 6–8 weeks old Dosage: 5 µg Administration: Nostril mucosal adjuvant Result: Higher titers of ovalbumin (OVA)-specific IgA and total IgG as well as IgG1 and IgG2c in the sera of mice immunized with cGAMP-adjuvanted OVA as compared to sera from OVA-immunized mice. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.483 ml | 7.414 ml | 14.828 ml |
5 mM | 0.297 ml | 1.483 ml | 2.966 ml |
10 mM | 0.148 ml | 0.741 ml | 1.483 ml |
5 mM | 0.03 ml | 0.148 ml | 0.297 ml |
Target
Target Value
STING
in vitro studies
cGAMP promotes the antigen-specific proliferation capacity of spleen cells in mice.
cGAMP directly activates murine and human dendritic cells in vitro.
On stimulation with cGAMP, fibroblasts from the patients showed increased transcription of IFNB1 but not of the genes encoding interleukin-1 (IL1), interleukin-6 (IL6), or tumor necrosis factor (TNF).
cGAMP activates the endoplasmic reticulum (ER)-resident receptor STING, thereby inducing an antiviral state and the secretion of type I IFNs.
In vivo studies
cGAMP promotes the antigen-specific cytokine production by spleen cells of immunized mice.
Animal Model: Female C57BL/6 (H-2b) mice 6-8 weeks old
Dosage: 5 µg
Administration: Nostril mucosal adjuvant
Result: Higher titers of ovalbumin (OVA)-specific IgA and total IgG as well as IgG1 and IgG2c in the sera of mice immunized with cGAMP-adjuvanted OVA as compared to sera from OVA-immunized mice.